Limb PainNCT03763708

SCS Research Study

A study testing Spinal Cord Stimulation in people with Limb Pain and Trunk Pain, run by MedtronicNeuro at 9 sites in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record

Search all trials

Trial summary

To characterize the effects of stimulation parameters on pain relief and other cohort specific outcomes. Read more about this study

Who is it for?: Ages 22 years and older
Conditions the study is for: Limb Pain, Trunk Pain
What is being tested?: Spinal Cord Stimulation
Type of treatment: Medical device
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 100 participants
Where: 9 sitesUnited States
Study dates: 12 Dec 2018to 13 Jan 2023
Phase: Interventional
Are there results?: Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 22 years and older
All sexes
No healthy volunteers
Adult, Older adult

Who may be able to join

22 years of age or older
Implanted with a Medtronic rechargeable neurostimulation system, for a labeled indication, for at least 1 month and expected longevity of neurostimulator is at least 5 months
Willing and able to provide signed and dated informed consent
Capable of comprehending and consenting in English
Willing and able to comply with all study procedures, including diary completion, and visits
Able to differentiate between pain associated with the indication for SCS implant and other types of pain

Who cannot join

Implanted with neurostimulation system for an off-label indication
Currently enrolled or planning to enroll in an interventional clinical study that could potentially confound the study results
If female, pregnant or is of child-bearing potential and unwilling to use a medically acceptable form of birth control during the study
Has untreated major psychiatric comorbidity
Has a non-rechargeable neurostimulator where the battery longevity is not able to be estimated with the battery longevity calculator

Trial locations and contacts

9 sites in 1 country.

City, postcode or hospital

9 sites in 1 country

United States9 sites

Regional Brain and Spine
Cape Girardeau, Missouri, 63701
Goodman Campbell Brain and Spine
Carmel, Indiana, 46032
Twin Cities Pain Clinic
Edina, Minnesota, 55439
Carolinas Research Institute
Huntersville, North Carolina, 28078
Center for Interventional Pain and Spine
Lancaster, Pennsylvania, 17601
Center for Pain and Supportive Care
Phoenix, Arizona, 85028
Pain Diagnostics and Interventional Care
Sewickley, Pennsylvania, 15143
Drez One
Somerset, Kentucky, 42503
Northwest Pain Care
Spokane, Washington, 99201

Other trials in United States

About this study

Official title: Spinal Cord Stimulation Research Study

To characterize the effects of stimulation parameters on pain relief and other cohort specific outcomes.

Conditions: Limb Pain, Trunk Pain
Being tested: Spinal Cord Stimulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Spinal Cord StimulationDevice
Programming

Study groups in NCT03763708
Study group	Role	What they receive
Cohort 1: Low Energy - Continuous	Experimental	Subjects will be programmed to a specific frequency with a long pulse width at various amplitudes Receives: Device: Spinal Cord Stimulation
Cohort 2: Interleaving	Experimental	Determine effects of delivering ping pulses combined with governed pulses while using separate sets of electrodes Receives: Device: Spinal Cord Stimulation
Cohort 3: Cycling Evolve	Experimental	Subjects will be programmed to high dose (HD) stimulation with various cycling parameters Receives: Device: Spinal Cord Stimulation
Cohort 4: Low Energy Cycling 1	Experimental	Effects of decreased pulse widths with increased frequency - with and without cycling parameters Receives: Device: Spinal Cord Stimulation
Cohort 5: Low Energy Cycling 2	Experimental	Effects of decreased pulse widths with increased frequency - with and without cycling parameters (different pulse widths and frequencies than Cohort 4) Receives: Device: Spinal Cord Stimulation
Cohort 6: Differential Targeted Multiplexed-Low Energy Spinal Cord Stimulation (DTM-LE SCS)	Experimental	Effects of decreased frequency and therapy cycling parameters Receives: Device: Spinal Cord Stimulation
Cohort 7: Super Cycle	Experimental	Effects of longer cycle duration Receives: Device: Spinal Cord Stimulation
Cohort 8: Differential Targeted Multiplexed (DTM) for Neuro Sense (NS)	Experimental	Effects of integrating Neuro Sense into DTM programming Receives: Device: Spinal Cord Stimulation
Cohort 9: Diabetic Peripheral Neuropathy (DPN) Flow	Experimental	Characteristics of vital signs in DPN participants Receives: Device: Spinal Cord Stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

Numeric Pain Rating Scale (NPRS) - Cohort 1
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Measured: Up to 5 months
Numeric Pain Rating Scale (NPRS) - Cohort 2
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Measured: Up to 2 months
Numeric Pain Rating Scale (NPRS) - Cohort 3
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Measured: Up to 3 months
Numeric Pain Rating Scale (NPRS) - Cohort 4
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Measured: Up to 5 months
Numeric Pain Rating Scale - Cohort 5
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Measured: Up to 5 months
Numeric Pain Rating Scale (NPRS) - Cohort 6
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Measured: Up to 7 months
Numeric Pain Rating Scale (NPRS) - Cohort 7
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Measured: Up to 8 months
Numeric Pain Rating Scale (NPRS) - Cohort 8
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Measured: Up to 0.5 months
Numeric Pain Rating Scale at Enrollment (NPRS) - Cohort 9
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Measured: Up to 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

12 Dec 201813 Jan 2023

First posted4 Dec 2018
Study start12 Dec 2018
Primary completion13 Jan 2023
Study completion13 Jan 2023

Why it stopped: Business temporarily suspended study January 2023 with intent to include additional cohorts in future. For business reasons, study terminated April 2024.

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
Other trials for Limb PainStudies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Treatment
Allocation: Non-randomised
Intervention model: Single group
Masking: None (open label)
Enrolment: 100 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT03763708
Sponsor's protocol ID: MDT18036
Status last verified: Dec 2024
First submitted: 3 Dec 2018
Last updated: 31 Dec 2024
Results posted: Yes, on ClinicalTrials.gov
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: Yes
Individual data sharing: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Active, not recruiting
Stabilization vs Corrective Exercise in PFP
Patellofemoral Pain Syndrome
RecruitingObservational study
Upper Extremity Exercise Capacity in Chronic Non-specific Neck Pain
Neck Pain
Not yet recruitingPhase 4
Role of Perineural Catheter in Pain Control and Opioid Consumption After Major Amputation of Lower Limb
Lower Limb Surgery, Pain
Not yet recruiting
Effects of Visual and Vestibular Rehabilitation in Individuals With Knee Osteoarthritis
Knee Osteoarthritis, Visual Rehabilitation
Recruiting
"Effect of Endermologie-Assisted Physiotherapy on Edema, Pain, and Functional Recovery After Liposuction for Lower-Limb Lipedema"
Lower-Limb Lipedema, Lipedema

All Limb Pain trials

Study at a glance

From the registry record, last updated by the sponsor on 31 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Spinal Cord Stimulation Research Study
ClinicalTrials.gov ID: NCT03763708
Acronym / sponsor ID: MDT18036
Conditions: Limb Pain, Trunk Pain
Study type: Interventional
Recruitment status: TerminatedReason stopped: Business temporarily suspended study January 2023 with intent to include additional cohorts in future. For business reasons, study terminated April 2024.
Enrolment: 100 participants (actual)
Lead sponsor: MedtronicNeuroIndustry (pharma, biotech, devices)
Study start: 12 Dec 2018 (actual)
Primary completion: 13 Jan 2023 (actual)
Study completion: 13 Jan 2023 (actual)
First posted: 4 Dec 2018 (actual)
Results: Posted 31 Dec 2024

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

To characterize the effects of stimulation parameters on pain relief and other cohort specific outcomes.

Study design

Primary purpose: Treatment
Allocation: Non-randomised
Intervention model: Single group
Masking: None (open label)
Number of arms: 9

Arm	Type	Receives
Cohort 1: Low Energy - Continuous	Experimental	Device: Spinal Cord StimulationSubjects will be programmed to a specific frequency with a long pulse width at various amplitudes
Cohort 2: Interleaving	Experimental	Device: Spinal Cord StimulationDetermine effects of delivering ping pulses combined with governed pulses while using separate sets of electrodes
Cohort 3: Cycling Evolve	Experimental	Device: Spinal Cord StimulationSubjects will be programmed to high dose (HD) stimulation with various cycling parameters
Cohort 4: Low Energy Cycling 1	Experimental	Device: Spinal Cord StimulationEffects of decreased pulse widths with increased frequency - with and without cycling parameters
Cohort 5: Low Energy Cycling 2	Experimental	Device: Spinal Cord StimulationEffects of decreased pulse widths with increased frequency - with and without cycling parameters (different pulse widths and frequencies than Cohort 4)
Cohort 6: Differential Targeted Multiplexed-Low Energy Spinal Cord Stimulation (DTM-LE SCS)	Experimental	Device: Spinal Cord StimulationEffects of decreased frequency and therapy cycling parameters
Cohort 7: Super Cycle	Experimental	Device: Spinal Cord StimulationEffects of longer cycle duration
Cohort 8: Differential Targeted Multiplexed (DTM) for Neuro Sense (NS)	Experimental	Device: Spinal Cord StimulationEffects of integrating Neuro Sense into DTM programming
Cohort 9: Diabetic Peripheral Neuropathy (DPN) Flow	Experimental	Device: Spinal Cord StimulationCharacteristics of vital signs in DPN participants

Who may qualify

Ages: 22 years and older
Sex: All
Healthy volunteers: Not accepted
Age groups: Adult, Older adult

Key inclusion criteria (6 listed)

22 years of age or older
Implanted with a Medtronic rechargeable neurostimulation system, for a labeled indication, for at least 1 month and expected longevity of neurostimulator is at least 5 months
Willing and able to provide signed and dated informed consent
Capable of comprehending and consenting in English
Willing and able to comply with all study procedures, including diary completion, and visits

Key exclusion criteria (5 listed)

Implanted with neurostimulation system for an off-label indication
Currently enrolled or planning to enroll in an interventional clinical study that could potentially confound the study results
If female, pregnant or is of child-bearing potential and unwilling to use a medically acceptable form of birth control during the study
Has untreated major psychiatric comorbidity
Has a non-rechargeable neurostimulator where the battery longevity is not able to be estimated with the battery longevity calculator

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
Spinal Cord StimulationProgramming	Device	Cohort 1: Low Energy - Continuous, Cohort 2: Interleaving, Cohort 3: Cycling Evolve, Cohort 4: Low Energy Cycling 1, Cohort 5: Low Energy Cycling 2, Cohort 6: Differential Targeted Multiplexed-Low Energy Spinal Cord Stimulation (DTM-LE SCS), Cohort 7: Super Cycle, Cohort 8: Differential Targeted Multiplexed (DTM) for Neuro Sense (NS), Cohort 9: Diabetic Peripheral Neuropathy (DPN) Flow

Primary outcome

Numeric Pain Rating Scale (NPRS) - Cohort 1
Time frame: Up to 5 months
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale (NPRS) - Cohort 2
Time frame: Up to 2 months
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale (NPRS) - Cohort 3
Time frame: Up to 3 months
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale (NPRS) - Cohort 4
Time frame: Up to 5 months
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale - Cohort 5
Time frame: Up to 5 months
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale (NPRS) - Cohort 6
Time frame: Up to 7 months
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale (NPRS) - Cohort 7
Time frame: Up to 8 months
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale (NPRS) - Cohort 8
Time frame: Up to 0.5 months
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale at Enrollment (NPRS) - Cohort 9
Time frame: Up to 1 month
To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.

Results and safety

Results posted to the registry on 31 Dec 2024, as reported by the sponsor. Figures are copied from the record, not re-analysed. Full results on ClinicalTrials.gov.

Participant flow

Group	Started	Completed
Cohort 1: Low Energy - Continuous	15	11
Cohort 2: Interleaving	0	0
Cohort 3: Cycling Evolve	0	0
Cohort 4: Low Energy Cycling 1	0	0
Cohort 5: Low Energy Cycling 2	0	0
Cohort 6: Differential Targeted Multiplexed-Low Energy Spinal Cord Stimulation (DTM-LE SCS)	0	0
Cohort 7: Super Cycle	0	0
Cohort 8: Differential Targeted Multiplexed (DTM) for Neuro Sense (NS)	0	0
Cohort 9: Diabetic Peripheral Neuropathy (DPN) Flow	0	0

Primary outcome: Numeric Pain Rating Scale (NPRS) - Cohort 1

Time frame: Up to 5 months. Mean (Standard Deviation). Unit: score on a scale

Measure	Cohort 1: Low Energy - Continuous Initial n = 14
Enrollment	5.2 (2.5)
Comfortable amplitude (Period 1)	4.9 (2.3)
80% comfortable amplitude (Period 2)	5.1 (2.3)
60% comfortable amplitude (Period 3)	4.9 (2.1)
40% comfortable amplitude (Period 4)	4.6 (2.1)
20% comfortable amplitude (Period 5)	4.7 (2.0)
0 mA/V (Period 6)	4.7 (1.9)
Comfortable amplitude with 25% duty cycle (Period 7)	4.3 (2.3)

Population analysed: Number analyzed refers to patients with measure available.

Primary outcome: Numeric Pain Rating Scale (NPRS) - Cohort 2

Time frame: Up to 2 months. Mean (Standard Deviation). Unit: score on a scale

Measure	Cohort 2: Interleaving n = 9
Enrollment	4.6 (2.46)
Follow-up (HD)	4.3 (2.48)
Follow-up (LD)	5.5 (1.33)

Primary outcome: Numeric Pain Rating Scale (NPRS) - Cohort 3

Time frame: Up to 3 months. Mean (Standard Deviation). Unit: score on a scale

Measure	Cohort 3: Cycling Evolve n = 4
Enrollment	4.0 (2.6)
Follow Up 1 (Came in at Cycling Off)	3.9 (2.4)
Follow Up 2 (Came in at Cycling ON)	4.9 (2.2)
Follow Up 3 (Came in at Cycling ON)	4.5 (2.1)
Follow Up 4 (Came in at Cycling ON)	4.7 (2.5)
Follow Up 5 (Came in at Cycling ON)	4.2 (2.4)
Final Study Visit (Came in at Cycling ON)	3.2 (2.2)

Population analysed: Number analyzed refers to patients with measure available.

Primary outcome: Numeric Pain Rating Scale (NPRS) - Cohort 4

Time frame: Up to 5 months. Mean (Standard Deviation). Unit: score on a scale

Measure	Cohort 4: Low Energy Cycling 1 n = 15
Enrollment	3.9 (3.0)
Low Energy 1, cycling off (Period 1)	4.9 (2.4)
Low Energy 1, cycling ON (Period 2)	5.1 (2.0)
Low Energy 1, cycling ON (Period 3)	5.6 (2.1)
Low Energy 2, cycling off (Period 4)	4.7 (2.3)
Low Energy 2, cycling ON (Period 5)	4.9 (2.3)
Low Energy 2, cycling ON (Period 6)	5.1 (2.4)
Low Energy 2, cycling ON (Period 7)	5.3 (2.4)

Population analysed: Number analyzed refers to patients with measure available.

Adverse events

Time frame: Cohort 1: 4.4 months Cohort 2: 1.5 months Cohort 3: 3.0 months Cohort 4: 2.1 months Cohort 5: 2.8 months Cohort 6: 6.8 months Cohort 7: 7.8 months Cohort 8: 0.5 months Cohort 9: 0.6 months. Other adverse events reported at 0% frequency or more

Group	Serious adverse events	Other adverse events	Deaths
Cohort 1: Low Energy - Continuous	0 of 15 (0%)	5 of 15 (33.3%)	0 of 15
Cohort 2: Interleaving	0 of 10 (0%)	1 of 10 (10%)	0 of 10
Cohort 3: Cycling Evolve	0 of 4 (0%)	0 of 4 (0%)	0 of 4
Cohort 4: Low Energy Cycling 1	0 of 15 (0%)	4 of 15 (26.7%)	0 of 15
Cohort 5: Low Energy Cycling 2	0 of 15 (0%)	2 of 15 (13.3%)	0 of 15
Cohort 6: Differential Targeted Multiplexed-Low Energy Spinal Cord Stimulation (DTM-LE SCS)	0 of 22 (0%)	3 of 22 (13.6%)	0 of 22
Cohort 7: Super Cycle	0 of 17 (0%)	3 of 17 (17.6%)	0 of 17
Cohort 8: Differential Targeted Multiplexed (DTM) for Neuro Sense (NS)	0 of 4 (0%)	0 of 4 (0%)	0 of 4
Cohort 9: Diabetic Peripheral Neuropathy (DPN) Flow	0 of 11 (0%)	0 of 11 (0%)	0 of 11

Loading the posted results from ClinicalTrials.gov…

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 31 Dec 2024.
Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Individual participant dataSharing planned: No

Related trials for Limb Pain

Active, not recruiting
Stabilization vs Corrective Exercise in PFP
Patellofemoral Pain Syndrome
RecruitingObservational study
Upper Extremity Exercise Capacity in Chronic Non-specific Neck Pain
Neck Pain
Not yet recruitingPhase 4
Role of Perineural Catheter in Pain Control and Opioid Consumption After Major Amputation of Lower Limb
Lower Limb Surgery, Pain
Not yet recruiting
Effects of Visual and Vestibular Rehabilitation in Individuals With Knee Osteoarthritis
Knee Osteoarthritis, Visual Rehabilitation
Recruiting
"Effect of Endermologie-Assisted Physiotherapy on Edema, Pain, and Functional Recovery After Liposuction for Lower-Limb Lipedema"
Lower-Limb Lipedema, Lipedema

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

The record lists no contact. Use the official record to reach the sponsor.

9 sites in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

A study testing Spinal Cord Stimulation in people with Limb Pain and Trunk Pain, run by MedtronicNeuro at 9 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 31 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 9 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 31 Dec 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Numeric Pain Rating Scale (NPRS) - Cohort 1 (time frame: Up to 5 months). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03763708.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Dec 2024.